News
Zacks Investment Research on MSN23h
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock UpShares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...
The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback